| Line Item | 2023-10-29 | Y/Y |
|---|---|---|
| Revenue | $35.82B | +7.9% |
| Cost of Revenue | $11.13B | +0.2% |
| Gross Profit | $24.69B | +11.7% |
| R&D Expense | $5.25B | +6.8% |
| SG&A Expense | $1.59B | +15.2% |
| Operating Income | $16.21B | +13.9% |
| Interest Expense | $1.62B | -6.6% |
| Pre-tax Income | $15.10B | +21.4% |
| Income Tax | $1.01B |
| Line Item | 2023-10-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.19B | +14.3% |
| Accounts Receivable | $3.15B | +6.6% |
| Inventory | $1.90B | -1.4% |
| Current Assets | $20.85B | +12.7% |
| Total Assets | $72.86B | -0.5% |
| Current Liabilities | $7.41B | +5.0% |
| Long-term Debt | $37.62B | -3.7% |
| Line Item | 2023-10-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.09B | +8.1% |
| Capital Expenditures | $452.0M | +6.6% |
| Investing Cash Flow | -$689.0M | -3.3% |
| Financing Cash Flow | -$15.62B | +1.2% |
| Free Cash Flow | $17.63B | +8.1% |
| +8.1% |
| Net Income | $14.08B | +22.5% |
| EPS (Basic) | $33.93 | +23.7% |
| EPS (Diluted) | $32.98 | +24.3% |
| Total Liabilities |
| $48.87B |
| -3.3% |
| Stockholders' Equity | $23.99B | +5.6% |